tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
HKEX:2196

Shanghai Fosun Pharmaceutical (Group) Co (2196) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2196 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Shanghai
Fosun Pharmaceutical (Group) Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2196 Stock 12 Months Forecast

There Are No Analyst Ratings for HK:2196 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

2196 Financial Forecast

2196 Earnings Forecast

Next quarter’s earnings estimate for 2196 is HK$0.44 with a range of HK$0.35 to HK$0.53. The previous quarter’s EPS was HK$0.21. 2196 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.42% of the time in the same period. In the last calendar year 2196 has Underperformed its overall industry.
Next quarter’s earnings estimate for 2196 is HK$0.44 with a range of HK$0.35 to HK$0.53. The previous quarter’s EPS was HK$0.21. 2196 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.42% of the time in the same period. In the last calendar year 2196 has Underperformed its overall industry.

2196 Sales Forecast

Next quarter’s sales forecast for 2196 is HK$10.59B with a range of HK$10.59B to HK$10.59B. The previous quarter’s sales results were ―. 2196 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 57.24% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.
Next quarter’s sales forecast for 2196 is HK$10.59B with a range of HK$10.59B to HK$10.59B. The previous quarter’s sales results were ―. 2196 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 57.24% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
HK$25.60
Hold
79.27%
Upside
Reiterated
10/31/23
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196:HK) PT Lowered to HK$25.60 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196:HK) to HK$25.60 (from HK$29.31) while maintaining a Neutral rating.

2196 Analyst Recommendation Trends

Rating
Oct 23
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
In the current month, 2196 has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 2196 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2196 Stock Forecast FAQ

What is HK:2196’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2196’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2196, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s share price target?
      Currently, no data Available
      What do analysts say about Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
      To buy shares of HK:2196, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis